Biomarkers Market, By Product Type (Biomarkers Test Kits, Biomarker Analyzer), By Application (Diagnostic Biomarkers, Monitoring Biomarkers, Drug discovery and development, Predictive biomarkers, Prognostic biomarkers), By Disease Indication (Cancer, Card

Biomarkers Market, By Product Type (Biomarkers Test Kits, Biomarker Analyzer), By Application (Diagnostic Biomarkers, Monitoring Biomarkers, Drug discovery and development, Predictive biomarkers, Prognostic biomarkers), By Disease Indication (Cancer, Cardiovascular disorders, Neurological Disorder, Infectious Disease, Others (Immunological Disorder, and Autoimmune Disorders among others )), By End User (Hospitals, Research laboratories, Diagnostic laboratories, Research and academic institute), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

A biomarker is a quantifiable sign of a biological condition or state. In order to investigate typical biological processes, pathogenic processes, or pharmacologic reactions to a therapeutic intervention, biomarkers are frequently examined and studied utilizing blood, urine, or soft tissues. Numerous scientific disciplines employ biomarkers. There are 2 types of biomarkers actively used in the market, they are Biomarker test Kits and Biomarker Analyzer. A relatively new set of clinical toolsets organized by clinical applications includes biomarkers utilized in the medical industry.

Market Dynamics

Increasing product launch by market players is expected to drive the market growth over the forecast period. For instance, on April 19, 2021, Amgen Inc., a global biotechnology company that uses science and innovation to translate novel concepts and medical discoveries into treatments for patients with life-threatening illnesses, announced the launch of the Biomarker Assist program, which aims to provide access to biomarker testing for patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker Assist.

Furthermore, on February 28, 2022, an initiative program was launched by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium aims to find the most effective blood tests for assessing a protein that is crucial for the early detection of rare neurodegenerative illnesses. The "Neurofilament as a Fluid Biomarker of Neuro degeneration in Familial Front temporal Degeneration (FTD)" study will demonstrate that one or more blood tests for this protein, known as neurofilament, can be used to determine individuals at risk of Front temporal Degeneration (FTD) due to genetic and familial ties. This is a crucial first step in developing a trustworthy, affordable, and non-invasive method to more accurately predict Front temporal Degeneration (FTD). Also, those who are at threat can take part in clinical studies of novel specifics, eventually leading to the development of treatments.

Key features of the study:

  • This report provides an in-depth analysis of the global biomarkers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biomarkers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Acobiom, Apis Assay Technologies Ltd., Eagle Biosciences, Inc., Beckman Coulter, Inc., PerkinElmer Inc., Biopanda Reagents Ltd, Quanterix, Secure Diagnostics Pvt. Ltd., BioVision Inc., Merck KGaA, R&D Systems, Life Diagnostics, QuantaMatrix Inc., Nanjing Synthgene Medical Technology Co., Ltd, LifeSpan BioSciences, Inc., Wako USA, BioLegend, Inc., Abnova Corporation, and Abbexa
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global biomarkers market
Detailed Segmentation:
  • Global Biomarkers Market, By Product Type:
  • Biomarker Test Kits
  • Biomarker Analyzer
  • Global Biomarkers Market, By Application:
  • Diagnostic Biomarkers
  • Monitoring Biomarkers
  • Drug Discovery And Development
  • Predictive Biomarkers
  • Prognostic Biomarkers
  • Global Biomarkers Market, By Disease Indication
  • Cancer
  • Cardiovascular Disease
  • Neurological Disorder
  • Infectious disease
  • Others (Immunological Disorder, and Autoimmune Disorders among others )
  • Global Biomarkers Market, By End User:
  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Research and Academic Institute
  • Global Biomarkers market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Agilent Technologies, Inc. *
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • F.Hoffmann-La Roche Ltd.
  • Acobiom
  • Apis Assay Technologies Ltd.
  • Eagle Biosciences, Inc.
  • Beckman Coulter, Inc.
  • PerkinElmer Inc.
  • Biopanda Reagents Ltd
  • Quanterix
  • Secure Diagnostics Pvt. Ltd.
  • BioVision Inc.
  • Merck KGaA
  • R&D Systems
  • Life Diagnostics
  • QuantaMatrix Inc.
  • Nanjing Synthgene Medical Technology Co. Ltd
  • LifeSpan BioSciences Inc
  • Wako USA,
  • BioLegend, Inc
  • Abnova Corporation
  • Abbexa
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Application
Market Snapshot, By Disease Indication
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunity
Impact Analysis
Key Developments
Industry Trends
Regulatory Scenario
Recent Product Approval/Launches
PEST Analysis
Porter’s Analysis
4. Global Biomarkers Market– Impact of Coronavirus (COVID-19) Pandemic
Impact on Demand
Impact on Healthcare
Epidemiology
5. Global Biomarkers Market, By Type, 2017 – 2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Biomarker Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn)
Biomarker Analyzers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
6. Global Biomarkers Market, By Application, 2017 – 2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Diagnostic Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn)
Monitoring Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Drug discovery and development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Predictive Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Prognostic Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
7. Global Biomarkers Market, By Disease Indication, 2017 – 2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn)
Cardiovascular Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Neurological Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn)
Infectious disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Others (Immunological Disorder, and Autoimmune Disorders among others )
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
8. Global Biomarkers Market, End User, 2017 – 2030 (US$ Billion)
Introduction
Market Share Analysis, By Region, 2022 and 2030(%)
Y-o-Y Growth Analysis, For Regions, 2017 - 2030
Regional Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017– 2030, (US$ Bn)
Research Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017– 2030, (US$ Bn)
Research and Academic Institute
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
9. Global Biomarker Market, By Region, 2017 – 2030 (US$ Billion)
Introduction
Market Share Analysis, By Region, 2022 and 2030(%)
Y-o-Y Growth Analysis, For Regions, 2017 - 2030
Regional Trends
North America
Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn)
U.S.
Canada
Latin America
Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Type, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Disease Indication, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By End User, 2017 – 2030 (US$ Bn)
South Africa
Central Africa
North Africa
10. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Agilent Technologies, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
F.Hoffmann-La Roche Ltd.
Acobiom
Apis Assay Technologies Ltd.
Eagle Biosciences, Inc.
Beckman Coulter, Inc.
PerkinElmer Inc.
Biopanda Reagents Ltd
Quanterix
Secure Diagnostics Pvt. Ltd.
BioVision Inc.
Merck KGaA
R&D Systems
Life Diagnostics
QuantaMatrix Inc.
Nanjing Synthgene Medical Technology Co., Ltd
LifeSpan BioSciences, Inc.
WakUSA
BioLegend, Inc.
Abnova Corporation
Abbexa
Analyst Views
11. Section
Research Methodology
About Us
*Browse 40 market data tables and 48 figures on “Global Biomarkers Market” - forecast t2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings